SCHNELL DAVID

Insider CIK 1162060 · VTAE 10% owner · NGM Director · KYTH Director, 10% owner

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
NGM NGM BIOPHARMACEUTICALS INC	A Award deriv	2020-05-20	2020-05-22	16,806	—	$0	16,806	SEC↗
NGM NGM BIOPHARMACEUTICALS INC	A Award deriv	2019-05-15	2019-05-17	24,000	—	$0	24,000	SEC↗
NGM NGM BIOPHARMACEUTICALS INC	C Conversion deriv	2019-04-08	2019-04-10	3,000,000	—	$0	0	SEC↗
NGM NGM BIOPHARMACEUTICALS INC	C Conversion deriv	2019-04-08	2019-04-10	1,300,000	—	$0	0	SEC↗
NGM NGM BIOPHARMACEUTICALS INC	C Conversion deriv	2019-04-08	2019-04-10	100,000	—	$0	0	SEC↗
NGM NGM BIOPHARMACEUTICALS INC	C Conversion deriv	2019-04-08	2019-04-10	525,000	—	$0	0	SEC↗
NGM NGM BIOPHARMACEUTICALS INC	C Conversion	2019-04-08	2019-04-10	4,925,000	—	$0	4,925,000	SEC↗
VTAE Vitae Pharmaceuticals, Inc	J Other	2015-03-24	2015-03-26	20,357	—	$0	28,237	SEC↗
VTAE Vitae Pharmaceuticals, Inc	J Other	2015-03-24	2015-03-26	20,357	—	$0	32,584	SEC↗
VTAE Vitae Pharmaceuticals, Inc	J Other	2015-03-24	2015-03-26	900,383	—	$0	1,672,140	SEC↗
VTAE Vitae Pharmaceuticals, Inc	C Conversion deriv	2014-09-29	2014-10-01	76,949	—	$0	0	SEC↗
VTAE Vitae Pharmaceuticals, Inc	C Conversion deriv	2014-09-29	2014-10-01	1,530,269	—	$0	0	SEC↗
VTAE Vitae Pharmaceuticals, Inc	C Conversion deriv	2014-09-29	2014-10-01	102,301	—	$0	0	SEC↗
VTAE Vitae Pharmaceuticals, Inc	C Conversion deriv	2014-09-29	2014-10-01	173,912	—	$0	0	SEC↗
VTAE Vitae Pharmaceuticals, Inc	C Conversion deriv	2014-09-29	2014-10-01	173,912	—	$0	0	SEC↗
VTAE Vitae Pharmaceuticals, Inc	C Conversion	2014-09-29	2014-10-01	102,301	—	$0	395,799	SEC↗
VTAE Vitae Pharmaceuticals, Inc	C Conversion	2014-09-29	2014-10-01	1,530,269	—	$0	1,823,767	SEC↗
VTAE Vitae Pharmaceuticals, Inc	C Conversion	2014-09-29	2014-10-01	76,949	—	$0	1,900,716	SEC↗
VTAE Vitae Pharmaceuticals, Inc	P Buy	2014-09-29	2014-10-01	671,807	$8.00	$5.37M	2,572,523	SEC↗
VTAE Vitae Pharmaceuticals, Inc	C Conversion	2014-09-29	2014-10-01	261,977	—	$0	293,498	SEC↗
VTAE Vitae Pharmaceuticals, Inc	C Conversion	2014-09-29	2014-10-01	261,977	—	$0	293,498	SEC↗
KYTH KYTHERA BIOPHARMACEUTICALS	A Award deriv	2014-06-05	2014-06-06	8,400	—	$0	8,400	SEC↗
KYTH KYTHERA BIOPHARMACEUTICALS	A Award deriv	2013-06-04	2013-06-06	6,618	—	$0	6,618	SEC↗
KYTH KYTHERA BIOPHARMACEUTICALS	C Conversion deriv	2012-10-16	2012-10-16	469,926	—	$0	0	SEC↗
KYTH KYTHERA BIOPHARMACEUTICALS	C Conversion deriv	2012-10-16	2012-10-16	118,013	—	$0	0	SEC↗
KYTH KYTHERA BIOPHARMACEUTICALS	C Conversion deriv	2012-10-16	2012-10-16	1,476	—	$0	0	SEC↗
KYTH KYTHERA BIOPHARMACEUTICALS	C Conversion deriv	2012-10-16	2012-10-16	1,314,831	—	$0	0	SEC↗
KYTH KYTHERA BIOPHARMACEUTICALS	C Conversion	2012-10-16	2012-10-16	469,926	—	$0	1,796,553	SEC↗
KYTH KYTHERA BIOPHARMACEUTICALS	C Conversion	2012-10-16	2012-10-16	118,013	—	$0	1,914,566	SEC↗
KYTH KYTHERA BIOPHARMACEUTICALS	C Conversion	2012-10-16	2012-10-16	1,476	—	$0	1,476	SEC↗
KYTH KYTHERA BIOPHARMACEUTICALS	C Conversion	2012-10-16	2012-10-16	1,325,151	—	$0	1,326,627	SEC↗
KYTH KYTHERA BIOPHARMACEUTICALS	A Award deriv	2012-10-10	2012-11-02	5,672	—	$0	5,672	SEC↗